PALO ALTO, Calif., Sept. 30, 2015 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) has appointed Rafael Torres to the position of senior vice president, business development and strategy. In this role, he leads the company's strategic plans for growth through acquisitions, investments, and partnerships that complement our current portfolio of businesses. He reports to Varian President and CEO Dow Wilson.
Rafael Torres, Senior Vice President of Business Development and Strategy at Varian Medical Systems
"Rafael Torres is uniquely qualified to lead our strategy and business development activities," said Wilson. "He brings over 14 years of healthcare strategic investing and business development experience, having served as global head of healthcare for GE Ventures and GE Equity, where he built a strategic investment portfolio of over 30 healthcare companies. He has significant global business development experience, which will be a tremendous asset as Varian continues to emphasize globalization of its market and operations."
Ad Statistics
Times Displayed: 112448
Times Visited: 6718 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
"It's an exciting time to join Varian, as the company is poised to take advantage of significant growth and expansion opportunities that leverage its market leadership in cancer treatment and imaging," said Torres. "With stakeholders navigating the current transition away from 'fee for service' to a 'fee for value' model in healthcare, our technologies and business models must support them in this transformation. Our growth themes will support Varian's globalization and foster a culture of disruptive innovation in order to maintain a technology leadership position."
Prior to joining Varian, Torres served as global head of healthcare for GE Ventures and GE Equity. He was a founding member of GE Ventures and a member of its senior leadership committee. Torres led the healthcare investment team and represented GE on portfolio company boards, including CardioDx, InSightec, LipoScience, Navinet and ParadigmHealth.
Torres was also a judge of the healthymagination Cancer Innovation Challenge and a member of the StartupHealth transformers advisory panel. He has been featured in healthcare publications and conferences including The Gray Sheet, MedDevice Daily, SXSW, Slush Digital Health and Biomed Israel. He held previous roles at The Boston Consulting Group and Citibank N.A.
Torres holds an MBA degree from Harvard Business School and a B.A. in economics from the Universidad del Pacifico in Lima, Peru.
